Description:

Gynecologic Oncology Group Pre-Treatment Summary Form (Form DR) Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4F539833-2C57-6522-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4F539833-2C57-6522-E044-0003BA3F9857

Keywords:
Versions (2) ▾
  1. 9/19/12
  2. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Fallopian Tube Cancer NCT00951496 Pre-Study - Gynecologic Oncology Group Pre-Treatment Summary Form (Form DR) - 2757969v1.0

No Instruction available.

  1. StudyEvent: Gynecologic Oncology Group Pre-Treatment Summary Form (Form DR)
    1. No Instruction available.
Header Module
Non-invasive Diagnostic Procedures
Chest X-Ray Result
EKG Result
MRI Result
CT Result
Other Procedure Performed
Are there any target lesions? (RECOMMENDED TERM: Are there any target lesions?)
Comments

Similar models